Schonfeld Strategic Advisors’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-79,205
| Closed | -$872K | – | 1918 |
|
|
2024
Q3 | $872K | Buy |
+79,205
| New | +$872K | 0.01% | 1076 |
|
|
2024
Q2 | – | Sell |
-20,820
| Closed | -$293K | – | 1996 |
|
|
2024
Q1 | $293K | Sell |
20,820
-15,280
| -42% | -$215K | ﹤0.01% | 1474 |
|
|
2023
Q4 | $277K | Sell |
36,100
-11,400
| -24% | -$87.6K | ﹤0.01% | 1365 |
|
|
2023
Q3 | $354K | Buy |
47,500
+1,000
| +2% | +$7.46K | ﹤0.01% | 1168 |
|
|
2023
Q2 | $387K | Sell |
46,500
-6,337
| -12% | -$52.8K | ﹤0.01% | 1273 |
|
|
2023
Q1 | $703K | Buy |
52,837
+15,737
| +42% | +$209K | 0.01% | 1049 |
|
|
2022
Q4 | $552K | Buy |
+37,100
| New | +$552K | ﹤0.01% | 1456 |
|
|
2022
Q2 | – | Sell |
-11,500
| Closed | -$77K | – | 2437 |
|
|
2022
Q1 | $77K | Buy |
+11,500
| New | +$77K | ﹤0.01% | 2215 |
|
|
2021
Q1 | – | Sell |
-7,933
| Closed | -$102K | – | 1734 |
|
|
2020
Q4 | $102K | Buy |
7,933
+5,600
| +240% | +$72K | ﹤0.01% | 1410 |
|
|
2020
Q3 | $86K | Buy |
+2,333
| New | +$86K | ﹤0.01% | 1242 |
|
|
2016
Q4 | – | Sell |
-333
| Closed | -$123K | – | 543 |
|
|
2016
Q3 | $123K | Buy |
+333
| New | +$123K | 0.02% | 389 |
|